cisapride has been researched along with Apnea, Sleep in 3 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gastrointestinal prokinetic agents, such as cisapride, are commonly used in pediatric practice to improve gastric emptying, to decrease emesis, to improve lower esophageal sphincter tone, and to improve irritability and feeding aversion associated with gastroesophageal reflux (GER)." | 9.09 | Cisapride decreases gastroesophageal reflux in preterm infants. ( Ariagno, RL; Baldwin, RB; Conrad, C; Kikkert, MA; Mirmiran, M, 2001) |
| "We studied the effects of positional treatment and cisapride (a new prokinetic agent) on the incidence and duration of gastroesophageal reflux in 22 infants (4-26 weeks old) in asleep, awake, fasted, and postcibal periods." | 7.67 | Gastroesophageal reflux incidence and respiratory dysfunction during sleep in infants: treatment with cisapride. ( Aerts, T; Deneyer, M; Sacre, L; Vandenplas, Y; Verlinden, M, 1989) |
| "Gastrointestinal prokinetic agents, such as cisapride, are commonly used in pediatric practice to improve gastric emptying, to decrease emesis, to improve lower esophageal sphincter tone, and to improve irritability and feeding aversion associated with gastroesophageal reflux (GER)." | 5.09 | Cisapride decreases gastroesophageal reflux in preterm infants. ( Ariagno, RL; Baldwin, RB; Conrad, C; Kikkert, MA; Mirmiran, M, 2001) |
| "We studied the effects of positional treatment and cisapride (a new prokinetic agent) on the incidence and duration of gastroesophageal reflux in 22 infants (4-26 weeks old) in asleep, awake, fasted, and postcibal periods." | 3.67 | Gastroesophageal reflux incidence and respiratory dysfunction during sleep in infants: treatment with cisapride. ( Aerts, T; Deneyer, M; Sacre, L; Vandenplas, Y; Verlinden, M, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koivusalo, AI | 1 |
| Pakarinen, MP | 1 |
| Wikström, A | 1 |
| Rintala, RJ | 1 |
| Ariagno, RL | 1 |
| Kikkert, MA | 1 |
| Mirmiran, M | 1 |
| Conrad, C | 1 |
| Baldwin, RB | 1 |
| Vandenplas, Y | 1 |
| Deneyer, M | 1 |
| Verlinden, M | 1 |
| Aerts, T | 1 |
| Sacre, L | 1 |
1 trial available for cisapride and Apnea, Sleep
| Article | Year |
|---|---|
Cisapride decreases gastroesophageal reflux in preterm infants.
Topics: Cisapride; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gast | 2001 |
2 other studies available for cisapride and Apnea, Sleep
| Article | Year |
|---|---|
Assessment and treatment of gastroesophageal reflux in healthy infants with apneic episodes: a retrospective analysis of 87 consecutive patients.
Topics: Cisapride; Enzyme Inhibitors; Esophageal pH Monitoring; Esophagoscopy; Female; Follow-Up Studies; Fu | 2011 |
Gastroesophageal reflux incidence and respiratory dysfunction during sleep in infants: treatment with cisapride.
Topics: Cisapride; Gastroesophageal Reflux; Humans; Infant, Newborn; Piperidines; Posture; Sleep Apnea Syndr | 1989 |